Biomarker Optimization of Spinal Cord Stimulation Therapies

Area of Science:

• Biomedical Engineering
• Neuroscience
• Pain Management

Background:

• Chronic pain management faces challenges due to nonspecific treatments and lack of objective response measures.
• Intradural stimulation devices aim to improve current delivery to targeted neural tissue.
• Identifying biomarkers is essential for optimizing device parameters and predicting treatment response.

Purpose of the Study:

• To critically evaluate current biomarker approaches for intradural spinal cord stimulation.
• To identify and assess promising biomarkers for managing chronic pain.
• To provide a reference for selecting biomarkers during device development.

Main Methods:

• Conducted a comprehensive literature survey of potential biomarkers for intradural spinal cord stimulation.
• Detailed review of promising biomarkers, their limitations, and suitability for chronic pain management.

Main Results:

• The absence of reliable biomarkers hinders the assessment of therapeutic efficacy in chronic pain.
• Metabolites, inflammatory markers, dynamic imaging signals, and genomics are potential modulators for stimulation devices.
• Current treatments often lead to significant fluctuations in pain control and side effects.

Conclusions:

• Ongoing efforts are focused on identifying effective biomarkers for spinal cord stimulation.
• Biomarker discovery holds promise for improving patient outcomes, reducing adverse events, and enabling personalized treatment.
• Novel biomarkers are expected to play a significant role in the future management of chronic pain.